John F. Chin
Director/Board Member bei ANTENGENE CORPORATION LIMITED
Vermögen: 233 244 $ am 31.03.2024
Aktive Positionen von John F. Chin
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ANTENGENE CORPORATION LIMITED | Director/Board Member | 18.08.2020 | - |
| Corporate Officer/Principal | 18.08.2020 | - | |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01.10.1998 | - |
Antengene Corporation Co., Ltd.
 Antengene Corporation Co., Ltd. Pharmaceuticals: MajorHealth Technology Antengene Corporation Co., Ltd. operates as a holding company. It engages in clinical development of drug candidates. The company was founded on June 15, 2016 and is headquartered in Shanghai, China. | Director/Board Member | - | - |
| Corporate Officer/Principal | - | - |
Karriereverlauf von John F. Chin
Ehemalige bekannte Positionen von John F. Chin
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CELGENE | Corporate Officer/Principal | 01.01.2005 | 01.01.2020 |
Ausbildung von John F. Chin
| Pepperdine University | Masters Business Admin |
| University of Arizona | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| China | 3 |
Operativ
| Corporate Officer/Principal | 4 |
| Director/Board Member | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ANTENGENE CORPORATION LIMITED | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Health Technology |
Antengene Corporation Co., Ltd.
Antengene Corporation Co., Ltd. Pharmaceuticals: MajorHealth Technology Antengene Corporation Co., Ltd. operates as a holding company. It engages in clinical development of drug candidates. The company was founded on June 15, 2016 and is headquartered in Shanghai, China. | Health Technology |
- Börse
- Insiders
- John F. Chin
- Erfahrung
